HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Aggressive Subsets of Metastatic Triple Negative Breast Cancer.

AbstractBACKGROUND:
Relative to other metastatic breast cancer subtypes, metastatic triple-negative breast cancer (mTNBC) has a shorter duration of response to therapy and worse overall survival. Among patients with mTNBC, it is hypothesized that inflammatory breast cancer (IBC) and young women have particularly aggressive phenotypes. We investigated clinical and cell-free DNA (cfDNA) characteristics of inflammatory-mTNBC and young-mTNBC.
PATIENTS AND METHODS:
We evaluated 158 patients with mTNBC who were stratified into 3 groups: (1) IBC; (2) patients aged 45 years or younger at primary diagnosis without IBC (non-IBC young); and (3) patients over age 45 at diagnosis without IBC. We evaluated clinicopathologic characteristics, sites of metastasis, survival outcomes, and the fraction of DNA in circulation derived from tumor (TFx).
RESULTS:
Analysis of metastatic sites revealed that young patients without IBC had the most frequent lung metastases (P = .002). cfDNA analyses of first sample showed that TFx was highest in the non-IBC young group but not elevated in the IBC group (analysis of variance P = .056 for first TFx). Individually, median overall survival from metastatic diagnosis for the IBC group was 15.2 months; for the non-IBC young group, 21.2 months, and for the non-IBC over 45 group, 31.2 months. Patients with IBC and young patients without IBC had worse prognosis relative to patients over 45 without IBC (log-rank P = .023).
CONCLUSIONS:
Among patients with mTNBC in this single-institution cohort, patients with IBC and young patients without IBC had significantly worse overall survival compared with patients over 45 without IBC. Young patients without IBC had significantly higher cfDNA TFx, whereas patients with IBC did not have elevated TFx despite a poor prognosis. These findings demonstrate that further analyses of mTNBC subsets are warranted.
AuthorsJasneet Singh, Sarah Asad, Yiqing Zhang, William Nock, Elizabeth Adams, Adrienne Damicis, Bhuvaneswari Ramaswamy, Nicole Williams, Heather A Parsons, Viktor A Adalsteinsson, Eric P Winer, Nancy U Lin, Ann H Partridge, Beth Overmoyer, Daniel G Stover
JournalClinical breast cancer (Clin Breast Cancer) Vol. 20 Issue 1 Pg. e20-e26 (02 2020) ISSN: 1938-0666 [Electronic] United States
PMID31631016 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2019 Elsevier Inc. All rights reserved.
Chemical References
  • Cell-Free Nucleic Acids
Topics
  • Adult
  • Age Factors
  • Breast (pathology)
  • Cell-Free Nucleic Acids (blood)
  • Female
  • Humans
  • Inflammatory Breast Neoplasms (blood, diagnosis, mortality, pathology)
  • Middle Aged
  • Neoplasm Staging
  • Retrospective Studies
  • Triple Negative Breast Neoplasms (blood, diagnosis, mortality, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: